Deep Learning in the Quest for Compound Nomination for Fighting COVID-19

Author(s): Maria Mernea, Eliza C. Martin, Andrei-José Petrescu*, Speranta Avram*

Journal Name: Current Medicinal Chemistry

Volume 28 , Issue 28 , 2021

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor


The current COVID-19 pandemic initiated an unprecedented response from clinicians and the scientific community in all relevant biomedical fields. It created an incredible multidimensional data-rich framework in which deep learning proved instrumental to make sense of the data and build models used in prediction-validation workflows that in a matter of months have already produced results in assessing the spread of the outbreak, its taxonomy, population susceptibility, diagnostics or drug discovery and repurposing. More is expected to come in the near future by using such advanced machine learning techniques to combat this pandemic. This review aims to unravel just a small fraction of the large global endeavors by focusing on the research performed on the main COVID-19 targets, on the computational weaponry used in identifying drugs to combat the disease, and on some of the most important directions found to contain COVID-19 or alleviating its symptoms in the absence of specific medication.

Keywords: SARS-CoV-2, deep learning, drug-target interactions, virtual screening, drug design, drug repurposing.

open access plus

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2021
Published on: 13 January, 2021
Page: [5699 - 5732]
Pages: 34
DOI: 10.2174/0929867328666210113170222

Article Metrics

PDF: 175